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Injury of peripheral nerves can trigger neuropathic pain, producing allodynia and
hyperalgesia via peripheral and central sensitization. Recent studies have focused on
the role of the insular cortex (IC) in neuropathic pain. Because the IC is thought
to store pain-related memories, translational regulation in this structure may reveal
novel targets for controlling chronic pain. Signaling via mammalian target of rapamycin
(mTOR), which is known to control mRNA translation and influence synaptic plasticity,
has been studied at the spinal level in neuropathic pain, but its role in the IC under these
conditions remains elusive. Therefore, this study was conducted to determine the role
of mTOR signaling in neuropathic pain and to assess the potential therapeutic effects of
rapamycin, an inhibitor of mTORC1, in the IC of rats with neuropathic pain. Mechanical
allodynia was assessed in adult male Sprague-Dawley rats after neuropathic surgery
and following microinjections of rapamycin into the IC on postoperative days (PODs)
3 and 7. Optical recording was conducted to observe the neural responses of the IC to
peripheral stimulation. Rapamycin reduced mechanical allodynia and downregulated the
expression of postsynaptic density protein 95 (PSD95), decreased neural excitability in
the IC, thereby inhibiting neuropathic pain-induced synaptic plasticity. These findings
suggest that mTOR signaling in the IC may be a critical molecular mechanism
modulating neuropathic pain.
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INTRODUCTION
Neuropathic pain is defined as pain initiated or caused by a primary lesion or dysfunction in
the nervous system (Merskey and Bogduk, 1994). It is characterized by allodynia, hyperalgesia
and spontaneous pain (Jaggi and Singh, 2011). Advancements in the understanding of chronic
pain followed the suggestion of a ‘‘pain memory’’ by Melzack (1990). Since then, studies
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have indicated that neuropathic pain is intimately related to
structural changes in the central nervous system (CNS), known
as neuronal plasticity (Banic et al., 2004; May, 2008; Géranton
et al., 2009; Latremoliere and Woolf, 2009; Seminowicz et al.,
2009; Saab, 2012; Blom et al., 2014).
Plasticity of neuronal synapses requires protein synthesis
and regulation for the formation of long-term memory (Banko
et al., 2005). Mammalian target of rapamycin (mTOR), a
serine-threonine protein kinase, initiates mRNA translation
plays in the nervous system and plays important roles in
cell proliferation and differentiation (Huang and Houghton,
2003; Liang et al., 2013). The activation of mTOR complex
1 (mTORC1) regulates protein synthesis by phosphorylating
downstream effectors, such as eukaryotic initiation factor 4E
binding protein 1 (4EBP1) and p70 ribosomal S6 protein
kinase (p70S6K), which influence a wide range of physiological
and pathological states (Hay and Sonenberg, 2004; Jaworski
and Sheng, 2006; Swiech et al., 2008), including neuropathic,
inflammatory and cancer-related pain (Jiménez-Díaz et al.,
2008; Géranton et al., 2009; Norsted Gregory et al., 2010).
One study showed that mTOR signaling regulates pain-related
synaptic plasticity in the entorhinal-hippocampal pathway in
a model of persistent peripheral nociception induced by
peripheral bee venom injections (Lyu et al., 2013). Moreover,
the levels of mTOR and extracellular signal-regulated kinase
(ERK)1 and ERK2 were increased in the cerebrospinal fluid-
contacting nucleus of the brainstem after nerve injury (Li
et al., 2015). In the spinal cords of rats with chronic
constriction injury, inhibition of mTOR with rapamycin reduces
the expression of postsynaptic density protein 95 (PSD95;
Zhang et al., 2013). PSD95 is enriched at excitatory synapses
and mediates important interactions with receptors, such
as Nmethyl-D-aspartate (NMDA) and a-amino-3-hydroxy-5-
methyl-4-isoxazolepropionic acid (AMPA) receptors (Kim et al.,
2007), which are essential elements in pain hypersensitivity
(Toyoda et al., 2009). Thus, PSD95 may have a role in synaptic
plasticity and pain hypersensitivity (Kalia et al., 2008; Kessels and
Malinow, 2009; Yasaka et al., 2009; Liu and Salter, 2010; Zhou
et al., 2011).
Clinical and basic studies persistently indicate critical roles
of the insular cortex (IC) in pain processing (Burkey et al.,
1999; Coffeen et al., 2011; Liu et al., 2013). Zhuo (2016)
reported plastic changes and long-term potentiation (LTP) in
the IC after injury. Moreover, human fMRI studies document
a relationship between the IC and chronic neuropathic pain
conditions (Garcia-Larrea and Peyron, 2013; Tseng et al., 2013),
and interestingly, rostral regions of the IC are activated during
noxious somatosensory stimulation (Coghill et al., 1999; Brooks
et al., 2002). The rostral agranular IC (RAIC) in rats is essential
for modulating nociception (Wu et al., 2016) and is implicated in
pain behavior (Burkey et al., 1996; Jasmin et al., 2003). Recently,
Jung et al. (2016) found that lesions in RAIC diminished
pain-related behaviors in neuropathic pain models. These results
suggest that the rostral part of the IC plays a crucial role in pain
processing.
Therefore, the aim of this study was to investigate
the role of the mTORC1 pathway in the IC after nerve
injury. In particular, we focused on the relationship
between the mTORC1 signaling and PSD95 or NMDA
receptor 2B (NMDAR2B), which has been implicated
to be associated with synaptic plasticity. The findings
from our research may provide the foundation for a new
molecular target, the mTOR pathway, for understanding
neuropathic pain and may contribute to potential therapeutic
applications.
MATERIALS AND METHODS
Experimental Animals
Adult male Sprague-Dawley rats, weighing 250–280 g (Harlan,
Koatec, Pyeongtaek, Korea) were housed in plastic cages
and allowed to acclimate to the colony room for 7 days
after arrival. Rats were maintained under 12-h light/dark
cycles with pellets and water provided ad libitum. All
experimental protocols in this study were in compliance with
the National Institutes of Health guidelines and approved
by the Institutional Animal Care and Use Committee
of Yonsei University Health System (permit no: 2013-
0276).
Cannula Implantation
Rats were anesthetized with sodium pentobarbital (50 mg/kg,
intraperitoneal ,[i.p.]) and in a stereotaxic frame. Guide cannulae
(28-gauge) were bilaterally implanted into the RAIC (1.0 mm
anterior to bregma, ±4.7 mm lateral from the midline, 5.8 mm
beneath the surface of the skull; Han et al., 2015; Jung et al., 2016;
Wu et al., 2016). Rats were allowed to recover for 1 week after
cannula implantation.
Neuropathic Surgery
Under sodium pentobarbital (50 mg/kg, i.p.) anesthesia,
branches of the left sciatic nerve were exposed. The tibial and
sural nerves were tightly ligated with 4-0 black silk and cut,
whereas the common peroneal nerve was left intact (nerve-
injured, NP group; Lee et al., 2000). Animals in the sham group
underwent the same procedure for exposing the sciatic nerve but
without injury.
Mechanical Allodynia Test
Mechanical hypersensitivity of the hind paw was assessed
before nerve injury and on postoperative day (POD) 1, 3 and
7 by a researcher blinded to the experimental conditions.
Rats were habituated for 30 min to the test chambers,
a metal mesh floor under plastic domes. Mechanical
allodynia was measured by assessing thresholds for hind
paw withdrawal to stimulation by an electrical von Frey
filament (UGO Basile, Varese, Italy). Licking or rapid
withdrawal of the hind paw was considered as a positive
response. The responses were measured eight times in 2–3 min
intervals. The mechanical forces were recorded for each
withdrawal of the hind paw. Testing was also performed
before and at 0.5, 1, 2, 4, 8, 12, 24 and 48 h after rapamycin
microinjection.
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Rapamycin Microinjection into the IC
Rapamycin (R-5000; LC Laboratories, Woburn, MA, USA)
was prepared in 0.06% dimethyl-sulfoxide (DMSO) diluted in
saline. Microinjections were performed on POD3 and POD7.
Rapamycin (0.5 µl of 600 nM) or an equivalent amount of
vehicle solution was infused into the IC bilaterally through the
injection cannulae using Hamilton syringes and PE-10 tubing.
The injection cannula was maintained in position for at least
1 min to allow for drug absorption.
Immunohistochemical Staining
Rats were anesthetized with urethane (1.25 g/kg, i.p.) and
perfused transcardially with normal saline (0.9% NaCl) followed
by a 4% solution of formaldehyde in 0.1 M sodium phosphate
buffer (pH 6.8). The brains were extracted and post-fixed
overnight at 4◦C before cryoprotecting in 30% sucrose in
phosphate-buffered saline (PBS, pH 7.4) for 24 h. Coronal
tissue sections (30 µm) were cut using a cryostat (Microm
HM525; Thermo Scientific, Waltham, MA, USA). The sections
were incubated with PBS containing 1% normal horse serum
for 30 min, and then incubated overnight in anti-c-Fos
(AB 1584, 1:4000; Merck Millipore, Darmstadt, Germany)
and phospho (p)-ERK (no. 5683, 1:2000; Cell Signaling
Technology, Danvers, MA, USA) antibodies at 4◦C. The
sections were washed with PBS and incubated for 30 min in
biotinylated antibody (1:50, Vector Laboratories, Burlingame,
CA, USA). The slides were then washed again and incubated
for 30 min with PBS containing the avidin-biotinylated
horseradish peroxidase complex (ABC kit; Vector Laboratories).
After washing, sections were incubated for 5–7 min in
a PBS solution containing 0.1% 3,3′-diaminobenzidine
tetrahydrochloride (DAB), 0.1% ammonium nickel sulfate,
and 10 µl of H2O2. The reaction was terminated by washing
with PBS. The slides were then dehydrated with ethanol,
cleared in xylene and covered with Permount (Thermo
Scientific).
c-Fos- and p-ERK-labeled cells in the ipsilateral and
contralateral sites of the rostral IC defined by the rat brain
atlas (Paxinos and Watson, 2006) were observed under light-
field microscopy (20× objective; Olympus, Tokyo, Japan). To
quantify c-Fos- and p-ERK-positive cells in the IC, a maximum
of eight representative sections of the IC were chosen at random
from each rat and counted by an observer blinded to the
experimental conditions. The numbers of positive cells from
each section were averaged to represent the cell count of each
animal. Regions of interest (ROIs) were set for the ipsilateral and
contralateral sides.
Western Blot Analysis
On POD 3 and 7, rats received microinjections of vehicle
solution or rapamycin as described above and were anesthetized
with Enflurane for decapitation and IC tissue sample collection.
The ipsilateral and contralateral rostral ICs were quickly
dissected, frozen on dry ice, and stored at −70◦C. For
protein extraction, samples were homogenized in lysis buffer
(ProPrep; Intron Biotechnology, Pyeongtaek, Korea) containing
phosphatase inhibitors (Phosstop; Roche,Mannheim, Germany).
Samples were then centrifuged at 12,000× g for 20 min
at 4◦C, and the supernatants were collected. Total protein
concentrations were assessed with a spectrophotometer
(Nano Drop ND-1000; Thermo Scientific), and 30 µg of
protein per well were denatured and run on 10% gels (Bio-
Rad, Hercules, CA, USA). Proteins were transferred onto
a polyvinylidene difluoride membrane (Merck Millipore,
Darmstadt, Germany), and the membranes were blocked
by incubating in 3% skim milk. Membranes were incubated
with primary antibodies against mTOR (no. 2972, 1:1000;
Cell Signaling Technology), p-mTOR (Ser 2448, no. 5536,
1:500; Cell Signaling Technology), P70S6K (no. 9202, 1:1000;
Cell Signaling Technology), p-P70S6K (Thr 389, no. 9234,
1:500; Cell Signaling Technology), 4EBP (no. 9452, 1:1000;
Cell Signaling Technology), p-4EBP (Thr37/46, no. 2855,
1:500; Cell Signaling Technology), PSD95 (no. 3450, 1:1000;
Cell Signaling Technology), NMDAR2B (no. 4207, 1:1000;
Cell Signaling Technology) and β-actin (no. 3700, 1:10,000;
Cell Signaling Technology). Membranes were then incubated
with the appropriate anti-rabbit or anti-mouse horseradish
peroxidase-conjugated secondary antibodies (no. 7074 and
7076, 1:10,000; Cell Signaling Technology). Proteins were
visualized by applying a chemiluminescent substrate (GE
Healthcare, Little Chalfont, UK) and observed using the
LAS system (LAS 4000; GE Healthcare). The signals for
phosphorylated proteins were normalized to those from
the nonspecific forms. β-actin was used as the loading
control.
Optical Imaging
Optical imaging was conducted as described in a previous
article (Han et al., 2016) with a slight modification. Before
imaging, 16 Sprague-Dawley male rats (250–300 g; n = 8/group)
were deeply anesthetized with urethane (1.25 g/kg, i.p.) on
POD 7 and given atropine (5 mg/kg, i.p.) to suppress mucus
secretion and dexamethasone sulfate (1 mg/kg, i.p.) to reduce
swelling of the brain. Rats were then placed on their sides in a
custom-made stereotaxic frame, which exposed the IC located
in the anterolateral aspect of the brain, and endotracheally
intubated to minimize respiratory movements during optical
imaging. Heart rates were monitored by electrocardiography
and body temperatures were maintained at 36◦C with a rectal
probe and heating pad system (homeothermic blanket control
unit; Harvard Apparatus, Holliston, MA, USA). Lidocaine
was applied to the right temporal muscle and the skin
contralateral to the injury. The skin overlying the temporalis
muscle and zygomatic arch was carefully removed to prevent
excessive bleeding. Craniectomies were performed and the
overlying dura were resected to expose the cortex. The
cortices were stained using a voltage-sensitive dye (di-2-
ANEPEQ, 50 µg/mL in saline; Molecular Probes, Eugene,
OR, USA) for 1 h and carefully rinsed with saline. Imaging
was performed before and after the application of vehicle
solution or 600 nM rapamycin directly to the exposed cortex
for 30 min. The changes in fluorescence were measured
using a high-resolution CCD camera (Brainvision, Inc., Tokyo,
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Japan) equipped with a dichroic mirror with a 510–550 nm
excitation filter and 590 nm absorption filter. A tungsten
halogen lamp (150 W) was used for excitation of fluorescence.
The imaging area was 6.4 × 4.8 mm2 and consisted of
184× 124 pixels.
A pair of stainless steel electrodes was inserted into the
left hind paws where the electronic von Frey filaments had
been applied during behavioral testing. The stimulation was
a square pulse (width: 0.1 ms, interstimulus interval: 5 s,
intensity: 5.0 mA) using a stimulus isolation unit (World
Precision Instruments, Sarasota, FL, USA). The fluorescence
intensity during each trial was detected for approximately
940 ms under an optical microscope (Leica Microsystems, Ltd.,
Heerbrugg, Switzerland) equipped with a 1× objective and a
1× projection lens. Optical signals were acquired at a rate of
3.7 ms/frame and averages of 30 trials were recorded by an
optical imaging recording system (MiCAM02; Brainvision, Inc.).
Optical imaging acquisition was triggered by electrocardiogram
signals using a stimulus/non-stimulus subtraction method. After
optical imaging, rats were euthanized by an overdose of
urethane.
To normalize the value of each pixel, the ratio of the
intensity of fluorescence (∆F) in each pixel relative to the
initial fluorescence intensity (F) was expressed as the fractional
change (∆F/F). Amplitudes and excitatory areas of optical
signals were measured using a spatial filter (9 × 9 pixels)
to reduce artifacts caused by vibration and brain movements.
Using captured images, fractional changes in optical signals
(optical intensity) and areas of activation were quantified.
Changes in optical intensity in the IC were expressed as a
percentage of fractional change in fluorescence (∆F/F × 100).
Activated areas were analyzed using the activated pixel
number of an ROI (previously described in Han et al.,
2016)/total pixel number of the ROI × 100. Data were
collected and analyzed with BV Analyzer software (Brainvision,
Inc.).
Statistical Analysis
Data from the behavioral tests were analyzed by two-way
analysis of variance (ANOVAs) with repeated measures,
with group and POD as factors, and by unpaired t tests
for post hoc comparisons between groups. Unpaired t tests
were performed for the analyses of immunohistochemistry,
Western blotting and optical imaging data. Statistical
analyses were performed by SPSS 20.0 software (IBM
Corporation, Armonk, NY, USA). All values are expressed
as means ± SEM. P values less than 0.05 were considered
statistically significant.
RESULTS
Nerve Injury Leads to the Development of
Mechanical Allodynia
We examined the time course of behavioral changes in
our neuropathic pain model (Lee et al., 2000) using the
thresholds of the injured hind paws at 1, 3 and 7 days
after the neuropathic pain surgery. From POD1 to POD7,
the thresholds between NP and sham groups (n = 6) were
significantly different (group, F(1,10) = 118.917, P < 0.001;
POD, F(3,30) = 16.159, P < 0.001; group and POD interaction,
F(3,30) = 29.537, P < 0.001; two-way repeated measured
ANOVA; Figure 1). The mechanical thresholds of the peripheral
nerve injury group were decreased compared with those of
the shams on POD1 (unpaired t test, P < 0.001), POD3
(unpaired t test, P < 0.001) and POD7 (unpaired t test,
P < 0.001).
Increased c-Fos and p-ERK Levels in the
IC of Rats after Nerve Injury
Several authors have proposed that the IC is activated under
various type of pain, including neuropathic pain (Alvarez
et al., 2009; Qiu et al., 2013). Figure 2A shows histological
confirmation of rostral IC with Paxinos and Watson’s rat atlas
(Paxinos and Watson, 2006). To confirm that the rostral IC
is involved with neuropathic pain, immunohistochemistry was
performed to assess the numbers of cells expressing c-Fos and
p-ERK, which are important markers for nociceptive neuronal
activation in the CNS (Gao and Ji, 2009). On POD3, rats
in the NP group had higher numbers of c-Fos- (Figure 2B,
the first row microphotographs and Figure 2C, the graph
of c-Fos-positive neurons, NP group (n = 5), Sham group
(n = 5), P < 0.001, unpaired t test) and p-ERK- (Figure 2B,
the second row microphotographs and Figure 2D, the graph
of p-ERK positive cells, NP group (n = 4), Sham group
(n = 4), P < 0.05, unpaired t test, scale bar: 200 µm)
positive cells than sham animals. The numbers of cells positive
for c-Fos (Figure 2B, the third row microphotographs and
Figure 2E, the graph of c-Fos-positive cells, NP group (n = 6),
FIGURE 1 | Development of mechanical allodynia in nerve-injured (NP)
and sham-injured (Sham) rats. After nerve injury, rats developed significant
neuropathic pain on postoperative day 1 (POD1), POD3 and POD7 compared
with the sham group. Data are presented as means ± SEM. ∗∗P < 0.01 vs.
Sham.
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FIGURE 2 | c-Fos and phospho (p)-extracellular signal-regulated kinase (ERK) expression in NP and Sham rats. (A) Histological clarification of rostral
insular cortex (IC) with rat atlas. Subdivisions of the IC were included in the black square box. c-Fos- and p-ERK-positive cells in the AIV and AID were analyzed. AIV,
agranular insular cortex ventral; AID, agranular insular cortex dorsal; DI, dysgranular insular cortex; GI, granular insular cortex; S2, secondary somatosensory cortex;
Den, dorsal endopiriform nucleus; VCI, ventral part of claustrum; DCI, dorsal part of claustrum. (B) Microphotographs of c-FOS and p-ERK in the rostral IC (AIV and
AID areas). The arrows mean positive cells for c-FOS or p-ERK. (C) Quantification of c-Fos- and (D) p-ERK-positive cells on POD3. (E) Quantification of c-Fos- and
(F) p-ERK-positive cells on POD7. Scale bars, 200 µm. Data are presented as means ± SEM. ∗P < 0.05, ∗∗P < 0.01 vs. Sham.
Sham group (n = 6), P < 0.01, unpaired t test) and p-ERK
(Figure 2B, the fourth row microphotographs and Figure 2F,
the graph of p-ERK-positive neurons, NP group (n = 6), Sham
group (n = 6), P < 0.01, unpaired t test) in nerve-injured
rats were also significantly higher than in sham controls on
POD7.
Nerve Injury Activates mTOR Signaling,
PSD95 and NMDAR2B Expressions in the
IC
On the basis of the above results, we hypothesized that chronic
pain derived from nerve injury alters mTOR signaling in the IC.
To test this, we measured protein and phosphorylation levels
of mTOR and its downstream targets, P70S6K and 4EBP, as
well as PSD95 and NMDAR2B expressions in the IC at three
and 7 days after nerve injury. The results indicate that on
POD 3, p-mTOR was upregulated in the NP group (n = 5)
compared with that in the sham group (n = 8; P < 0.05,
unpaired t test), with no difference in the total amounts of
mTOR (Figures 3A,B). Furthermore, phosphorylation levels of
its downstream targets P70S6K and 4EBP were upregulated
significantly in the NP group compared with those in shams
(p-P70S6K: NP, n = 5; sham, n = 5, P < 0.05, unpaired t test;
p-4EBP: NP, n = 4; sham, n = 4, P < 0.01, unpaired t test;
Figures 3C,E). There were no changes in total P70S6K and 4EBP
levels (Figures 3D,F, P > 0.05). Additionally, the expression of
PSD95 in the NP group (n = 5) was higher than in the sham
group (n = 5; Figure 3G, P < 0.05, unpaired t test). The level
of NMDAR2B was increased in the NP group (n = 7) compared
with the Sham group (n = 7; Figure 3H, P < 0.05, unpaired
t test).
Similarly, mTOR signaling activity was elevated in the NP
groups compared with that in the shams on POD7. Levels of
p-mTOR (Figure 4A) and p-P70S6K (Figure 4C) in the NP rats
(n = 4) were higher than in the sham group (n = 4; P < 0.01,
unpaired t tests). 4EBP activity measured by p-4EBP expression
was also increased in the NP group (Figure 4E; n = 4 each,
Frontiers in Molecular Neuroscience | www.frontiersin.org 5 March 2017 | Volume 10 | Article 79
Kwon et al. mTOR Signaling in the IC with Neuropathic Pain
FIGURE 3 | Phosphorylation of mammalian target of rapamycin (mTOR), p70 ribosomal S6 protein kinase (P70S6K) and 4E binding protein (4EBP),
and expression of postsynaptic density protein 95 (PSD95) and NMDAR2B in the IC on POD3 after nerve injury. (A,B) p-mTOR increased in the NP group
compared with the Sham group, but total mTOR levels were not significantly different on POD3. (C,D) p-P70S6K increased in the NP group compared with the Sham
group, but total P70S6K levels were not different. (E,F) p-4EBP increased in the NP group compared with the Sham group, but total 4EBP levels were not different.
(G,H) PSD95 and NMDAR2B levels increased significantly in the NP group compared with the Sham group. The intensity of the phospho-form band was normalized
to that of the total form, and the total form bands were normalized to β-actin protein. Data are presented as means ± SEM. ∗P < 0.05, ∗∗P < 0.01 vs. Sham.
P < 0.05, unpaired t test). There were no differences in total
levels of mTOR, P70S6K, and 4EBP (Figures 4B,D,F; Ps> 0.05).
The levels of PSD95 on POD7 were significantly higher in NP
rats than in sham controls (Figure 4G; n = 4 each, P < 0.05,
unpaired t test). Finally, the expression level of NMDAR2B
increased significantly in the NP group (n = 6) compared with
the Sham group (n = 6; Figure 4H, P < 0.05, unpaired t test).
These results suggest that mTOR pathway in the IC strongly
is related to PSD95 and NMDAR, and lead to neuropathic
pain.
Microinjection of Rapamycin in the IC
Diminishes Mechanical Allodynia in Rats
with Neuropathic Pain
Previous studies demonstrated that intrathecal or systemic
rapamycin administration reduces neuropathic pain (Asante
et al., 2010; Melemedjian et al., 2013). To determine if this is
due to effects in the IC, rats with neuropathic pain received
microinjections of rapamycin (600 nM; n = 11–12) or the vehicle
(n = 9–11) after mechanical allodynia testing on POD3 and
POD7 (Figures 5A,B). Microinjection of rapamycin into the IC
significantly affected withdrawal thresholds on POD3 (group,
F(1,20) = 18.171, P < 0.001; time, F(8,160) = 10.8209, P < 0.001;
group× time interaction, F(8,160) = 5.191, P< 0.001; n = 11 each,
two-way repeated measured ANOVA; Figure 5C). The analgesic
effect of rapamycin in comparison with the vehicle persisted for
up to 24 h after the microinjection as measured by mechanical
allodynia (0.5 h, P < 0.01; 1 h, P < 0.01; 2 h, P < 0.01;
4 h, P < 0.01; 8 h, P < 0.01; 12 h, P < 0.01; 24 h,
P < 0.05, unpaired t tests). However, there was no difference
in the withdrawal thresholds between the rapamycin and vehicle
groups 48 h after injection (respectively, P > 0.05, unpaired
t test).
Similar results were observed when microinjections were
performed on POD7. Figure 5D shows that microinjection
of rapamycin on POD7 decreased mechanical allodynia
significantly in comparison with rats receiving the vehicle
(group, F(1,19) = 14.546, P < 0.01; time, F(8,152) = 6.510,
P < 0.001; group × time interaction, F(8,152) = 3.223, P < 0.01;
rapamycin, n = 12; vehicle, n = 9, two-way repeated measured
ANOVA). Mechanical thresholds in the rapamycin-treated
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FIGURE 4 | Phosphorylation of mTOR, P70S6K and 4EBP and expressions of PSD95 and NMDAR2B in the IC on POD7 after nerve injury.
(A,B) p-mTOR increased in the NP group compared with the Sham group, but total mTOR levels were not significantly different on POD7. (C,D) p-P70S6K increased
in the NP group compared with the Sham group, but total P70S6K levels were not different. (E,F) p-4EBP increased in the NP group compared with Sham group,
but total 4EBP levels were not different. (G,H) PSD95 and NMDAR2B levels increased significantly in the NP group compared with the Sham group. The intensity of
the phospho-form band was normalized to that of the total form, and the total form bands were normalized to β-actin protein. Data are presented as means ± SEM.
∗P < 0.05, ∗∗P < 0.01 vs. Sham.
group increased compared with the vehicle group from
1 h to 24 h after the injections (0.5 h, P > 0.05; 1 h,
P < 0.05; 2 h, P < 0.01; 4 h, P < 0.001; 8 h, P < 0.01;
12 h, P < 0.05; 24 h, P < 0.05; 48 h, P > 0.05, unpaired
t tests).
mTOR Inhibition Reduces Pain-Related
Activation of the IC of Nerve-Injured
Animals
We assessed whether the inhibition of mTOR by rapamycin
reduces the expression of markers of nociceptive activation
in the IC 3 h after rapamycin/vehicle injections (Figure 6A).
On POD3, rats receiving rapamycin injections had reduced
number of cells positive for c-Fos (Figure 6B, the first
row microphotographs and Figure 6C, the graph of c-Fos
positive neurons, Rapa group (n = 6), Vehicle group (n = 6),
P < 0.01, unpaired t test) and p-ERK (Figure 6B, the second
row microphotographs and Figure 6D, the graph of p-ERK
positive cells, Rapa group (n = 6), Vehicle group (n = 6),
P < 0.05, unpaired t test) in the IC compared with in
rats receiving the vehicle. Similarly on POD7, rats receiving
rapamycin injections had reduced numbers of cells positive
for c-Fos (Figure 6B, the third row microphotographs and
Figure 6E, the graph of c-Fos positive cells, Rapa group
(n = 4), Vehicle group (n = 4), P < 0.001, unpaired t test)
and p-ERK (Figure 6B, the fourth row microphotographs
and Figure 6F, the graph of p-ERK positive neurons, Rapa
group (n = 4), Vehicle group (n = 4), P < 0.001, unpaired
t test).
Intracranial Administration of Rapamycin
Blocks mTOR Signaling, PSD95 and
NMDAR2B Expression in the IC of
Nerve-Injured Animals
We also assessed the levels of mTOR activation in the IC
3 h after rapamycin/vehicle injections; Figure 6A). On POD3,
rats receiving rapamycin injections had lower expression of
p-mTOR than vehicle-treated rats (Figure 7A; n = 5, P < 0.05,
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FIGURE 5 | Intracranial administration of rapamycin attenuates mechanical hypersensitivity. (A) Experimental schematic highlighting the time points of
cannula implantation, nerve injury, microinjection and behavioral testing. (B) Microinjection site into the IC (left) and a representative photograph of a coronal section
(right). Scale bar, 1 mm. (C) Changes in paw withdrawal thresholds to mechanical stimulation after microinjection of rapamycin (Rapa group, Rapa) or vehicle (Vehicle
group, Vehicle) on POD3. The arrow indicates the time point of microinjection. Significant differences between the rapamycin and vehicle groups were observed
between 0.5 h and 24 h after microinjection. (D) Changes in paw withdrawal thresholds to mechanical stimulation after microinjection of rapamycin or vehicle on
POD7. The arrow indicates the time point of microinjection. Similarly, the rapamycin and vehicle groups were significantly different between 1 h and 24 h after
microinjection. Data are presented as means ± SEM. ∗P < 0.05, ∗∗P < 0.01 vs. Vehicle.
unpaired t test), as well as decreased phosphorylation of P70S6K
and 4EBP (Figures 7C,E; n = 4 each, P < 0.01, unpaired
t tests). However, the levels of mTOR, P70S6K and 4EBP
were not significantly different (Figures 7B,D,F; P > 0.05).
Additionally, the expressions of PSD95 and the NMDAR2B
were decreased significantly with rapamycin compared with
the vehicle (Figures 7G,H; n = 5 each, P < 0.05, unpaired
t tests).
On POD7, rats received microinjections of rapamycin
or vehicle and mTOR activity and PSD95 expression were
measured. The phosphorylation of mTOR was decreased
significantly on POD7 in rats receiving rapamycin (Figure 8A;
n = 4, P < 0.001, unpaired t test). Similarly, phosphorylation
levels of P70S6K (Figure 8C; n = 4, P < 0.05, unpaired
t test) and 4EBP (Figure 8E; n = 4, P < 0.01, unpaired
t test) in the rapamycin-treated group were downregulated
compared with in the vehicle-treated group. The expression
levels of total mTOR, P70S6K and 4EBP were not significantly
different (Figures 8B,D,F; P> 0.05). In addition, the expressions
of PSD95 and the NMDAR2B in the rapamycin group were
significantly decreased on POD7 compared with in the vehicle
group (Figure 8G; n = 4, P < 0.01, Figure 8H; Rapa
group (n = 5), Vehicle group (n = 5), P < 0.05, unpaired
t tests).
Administration of Rapamycin Reduced
Excitability of the IC Induced by Peripheral
Electrical Stimulation
The ICs of nerve-injured rats were imaged to elucidate the
optical signal changes following electrical stimulation of the
hind paw (5.0 mA) of the hind paw (Figure 9). Each image
in response to stimulation before and after drug treatment is
shown and color coded to indicate optical signals according
to the changes in reflected light intensity (%∆F/F). Figure 9A
shows representative images taken before and after vehicle
treatment. Figure 9B shows the corresponding images before
and after rapamycin treatment. Wave forms were obtained
from the points indicated in each image. The IC after the
rapamycin treatment was rarely activated compared with that
before treatment.
Peak amplitudes and the activated areas of the IC
are represented in Figures 9C,D, respectively. Peak
amplitudes induced by peripheral electrical stimulation
after rapamycin treatment were reduced compared with
those before rapamycin treatment (Figure 9C; n = 8,
P < 0.01). The activated areas were also significantly
reduced following peripheral electrical stimulation
after rapamycin treatment compared with those before
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FIGURE 6 | Microinjection of rapamycin reduces the markers of nociceptive activation. (A) Experimental schematic highlighting the time points of cannula
implantation, nerve injury, microinjection and perfusion. (B) Microphotographs of c-FOS and p-ERK in the rostral IC. The arrows mean positive cells for c-FOS or
p-ERK. On POD3, (C) the numbers of c-Fos-positive and (D) p-ERK-positive cells decreased significantly in the Rapa group compared with in the Vehicle group. On
POD7, (E) the numbers of c-Fos-positive and (F) p-ERK-positive cells decreased significantly in the Rapa group compared with in the Vehicle group. Data are
presented as means ± SEM. ∗P < 0.05, ∗∗P < 0.01 vs. Vehicle.
rapamycin treatment (Figure 9D; n = 8, P < 0.01).
However, peak amplitudes and activated areas were not
significantly different before and after vehicle treatment
(Figures 9C,D).
DISCUSSION
Many studies have focused on the processes involved in
neuropathic pain, and controlling neuropathic pain remains
important (Ro and Chang, 2005). This study demonstrates
that neuropathic pain after nerve injury is accompanied
by considerable changes in the biochemistry and neuronal
activity of the IC. More specifically, nerve injury increases the
phosphorylation an activation of mTOR in the IC. To our
knowledge, this is the first study to investigate the role of the
mTOR signaling pathway and the potential effects of rapamycin
in the IC using a neuropathic pain model.
Rapamycin has been used as an anticancer and
immunosuppressive agent in clinical treatment (Populo
et al., 2012; Tateda et al., 2017). Because the side effects from
rapamycin are relatively low compared to with other drugs,
it has also been widely used in chronic pain treatments (Lee
et al., 2006; Alamo et al., 2009). Intrathecal, intraplantar
and systemic injection of rapamycin alleviate mechanical
hypersensitivity in formalin-induced pain models (Asante
et al., 2009) as well as capsaicin-induced hyperalgesia
(Géranton et al., 2009). Rapamycin may also reduce mechanical
allodynia under inflammatory pain conditions (Obara et al.,
2011).
Rapamycin is an inhibitor of mTOR, a molecule fundamental
in cell growth and metabolism (Laplante and Sabatini, 2012).
The activation ofmTOR triggers phosphorylation of downstream
effectors, such as P70S6K and 4EBP, to regulate mRNA
translation and protein synthesis (Shih et al., 2012; Zhuang
et al., 2016). Despite accumulating evidence supporting the
role of mTOR signaling in pain-related memory processing
(Zhang et al., 2013; Lutz et al., 2015), little is known about
the molecular mechanisms of this pathway in the brain. In
this study, we used behavioral, immunohistochemical, western
blot and optical imaging analyses to demonstrate that mTOR
signaling in the IC contributes to neuropathic pain and
regulates mechanical hypersensitivity. Inhibition of this pathway
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FIGURE 7 | Microinjection of rapamycin reversed the upregulation of the mTOR pathway and expressions of PSD95 and NMDAR2B on POD3 after
nerve injury. (A,B) p-mTOR levels decreased in the Rapa group compared with in the Vehicle group, but total mTOR levels were not significantly different. (C,D)
p-P70S6K levels decreased in the Rapa group compared with in the Vehicle group, but total P70S6K levels were not different. (E,F) p-4EBP levels decreased in the
Rapa group compared with in the Vehicle group, but total 4EBP levels were not different. (G) PSD95 and (H) NMDAR2B levels decreased in the Rapa group
compared with in the Vehicle group. Data are presented as means ± SEM. ∗P < 0.05, ∗∗P < 0.01 vs. Vehicle.
by microinjections of rapamycin increased the pain threshold
and reduced mechanical hypersensitivity on POD3 and POD7.
Our findings are compatible with the results of previous data
regarding mTOR (Asante et al., 2010; Norsted Gregory et al.,
2010; Zhang et al., 2013). However, the analgesic effect did
not persist beyond 24 h after microinjection, and further
studies are needed to assess the duration of rapamycin’s
efficacy.
The IC is involved in several sensory and cognitive processes,
such as learning, memory and perception (Bermúdez-Rattoni,
2004; Craig, 2011), and connects with other regions to
influence other higher-level functions, such as pain-perception
and decision-making (Zhuo, 2016). While the IC plays an
important role in pain processing (Alvarez et al., 2009;
Coffeen et al., 2011; Qiu et al., 2014), the plasticity of this
region in pain-related animal models remains unclear. It
was shown that nociceptive stimuli activate neurons in the
IC, as evidenced by increases in c-Fos (Gao and Ji, 2009),
an immediate early marker of activation (Greenberg et al.,
1986; Hunt et al., 1987; Coggeshall, 2005). A previous study
indicated that the role of p-ERK was cell proliferation and
differentiation (Widmann et al., 1999). Additionally, p-ERK
has been implicated in synaptic plasticity related to memory
and pain hypersensitivity (Ji and Woolf, 2001; Ji et al., 2003;
Price and Inyang, 2015). We show that c-Fos and p-ERK
levels are increased in the IC following nerve injury, suggesting
that this brain region is closely related to the pain state.
Importantly, these changes were attenuated by microinjections
of rapamycin, indicating the mTOR signaling pathway as
a mechanism for plastic changes regulating neuropathic
pain.
Accordingly, we observed that nerve injury increased the
expression of PSD95, an essential scaffold protein in the post
synaptic density of excitatory synapses (Tao et al., 2003; Zhang
et al., 2013). A previous study showed that the expression of
PSD95 significantly increases when mTOR-dependent pathways
are activated under stress conditions (Yang et al., 2008).
Our results similarly demonstrate that neuropathic pain
increases mTOR signaling and PSD95 expression. Moreover,
levels of PSD95 in the IC were decreased by inhibition
of mTOR with rapamycin. Interestingly, the knockdown of
PSD95 in the spinal cord delays the progression of neuropathic
pain (Tao et al., 2001, 2003). In our studies, mechanical
allodynia as a result of peripheral nerve injury appears to
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FIGURE 8 | Microinjection of rapamycin reversed the upregulation of the mTOR pathway and expressions of PSD95 and NMDAR2B on POD7 after
nerve injury. (A,B) p-mTOR levels decreased in the Rapa group compared with in the Vehicle group, but total mTOR levels were not significantly different.
(C,D) p-P70S6K levels decreased in the Rapa group compared with in the Vehicle group, but total P70S6K levels were not different. (E,F) p-4EBP levels decreased
in the Rapa group compared with in the Vehicle group, but total 4EBP levels were not different. (G) PSD95 and (H) NMDAR2B levels decreased significantly in the
Rapa group compared with in the Vehicle group. The intensity of the phospho-form band was normalized to that of the total form, and the total form bands were
normalized to β-actin protein. Data are presented as means ± SEM. ∗P < 0.05, ∗∗P < 0.01 vs. Vehicle.
be regulated by mTOR-dependent synthesis of PSD95 in the
IC. Taken together, these data suggest that mTOR signaling
maintains chronic pain conditions via regulation of synaptic
proteins.
Interestingly, there is a report that mTOR activation requires
activation of NMDA receptors in a bone cancer-induced pain
model (Shih et al., 2012). In a neuropathic pain model,
microinjection of an NMDA receptor antagonist into the
IC significantly reduced pain behavior (Liu et al., 2013).
Furthermore, LTP of synaptic responses in the IC is NMDA
receptor dependent (Liu et al., 2013), and inhibition of protein
synthesis or of the mTOR pathway can diminish LTP and
memory (Melemedjian and Khoutorsky, 2015). These data
suggest that LTP in the IC regulates neuropathic pain. Our
data support this, as NMDA receptor expression in the IC
was increased after peripheral nerve injury and attenuated by a
microinjection of rapamycin.
As an additional means to demonstrate neuronal activation in
the IC under neuropathic pain conditions, we performed optical
imaging using a voltage-sensitive dye. This electrophysiological
technique enables us to visualize the activity of large populations
of neurons, which is observed as changes in membrane
potentials. Because it has a high spatiotemporal resolution,
several studies have reported the excitatory propagation patterns
of pain-related brain areas (Kobayashi et al., 2010; An et al., 2012;
Fehérvári et al., 2015). Our previous study (Han et al., 2016)
showed that peripheral nerve injury increases the excitability
and induces plastic changes in the IC. Here, we demonstrate
that mTOR contributes to the chronic pain state, specifically in
relation to synaptic plasticity. However, no studies have reported
on the spatiotemporal pattern of the IC after mTOR inhibitor
treatment in a neuropathic pain model. Therefore, we recorded
optical signals induced by electrical stimulation of the hind paw
to investigate the excitatory patterns in the IC with and without
rapamycin treatment. The results of this study show an increase
in excitability after nerve injury, consistent with the results of
our previous study (Han et al., 2016). Furthermore, we show
that this excitability is reduced after treatment with an mTOR
inhibitor.
Even though mTOR signaling in the IC is involved in
pain modulation, mTOR signaling pathway in other brain
areas cannot be excluded to be involved in pain perception
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FIGURE 9 | Changes in optical signals before and after treatment with rapamycin and vehicle. (A) Optical signals before and after vehicle treatment.
(B) Optical signals before and after rapamycin treatment. (C) Peak amplitudes before and after vehicle and rapamycin treatments following peripheral electrical
stimulation with 5.0 mA intensity. (D) Activated areas before and after vehicle and rapamycin treatments following peripheral electrical stimulation with 5.0 mA
intensity. The peak amplitudes and activated areas induced by peripheral electrical stimulation after rapamycin treatment were reduced compared with those before
rapamycin treatment. However, they are not significantly different in both before and after vehicle treatment. ∗P < 0.05, ∗∗P < 0.01.
and modulation. In this regard, we tried to observe changes
in the expressions of mTOR signaling in the secondary
somatosensory cortex (S2) after administration of rapamycin.
After the microinjection of rapamycin into the S2, the expression
levels of p-mTOR and total mTOR were not changed compared
with the expression levels prior to the injection (Supplementary
Figure S1). This result indicates that the involvement of
mTOR signaling in pain modulation may vary in different
areas of the brain. Therefore, further studies may be necessary
to elucidate the role of mTOR signaling in other brain
areas that are likely to be involved in pain perception and
modulation.
In conclusion, this study suggests that the mTOR pathway is a
critical molecular signaling pathway regulating synaptic plasticity
in the IC and mechanical hypersensitivity after peripheral nerve
injury and neuropathic pain.
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